Kategorien
-
Adhesives
6
Amines
115
Amino Acids
210
Analytical Reagents
751
Antibiotics
275
Bioactive Small Molecules
806
Aroma Chemicals
247
Biochemicals
1158
Boronic Acids
4
Buffers
105
Building Blocks
2196
Carbohydrates
193
Catalysts
120
Chiral Compounds
77
Coccus nucifera oil
0
Detergents
63
Diagnostic Raw Materials
273
Flavours and Fragrance Materials
236
Fluorinated Products
68
Furans
7
Gases in Solution
53
Grignard Reagents
32
HPLC Reagents
8
Imidazoles
19
Indoles
48
Inorganic Chemicals
360
Ion-Pair Reagents
21
Ligands
81
Organics
1651
Oxazoles
3
Peptide Reagents
102
Phenols
55
Picolines
0
Piperazines
13
Pyrazines
3
Pyridines
69
Pyrimidines
36
Quaternary Ammonium salts
45
Reagents
114
Research Organics & Inorganics
895
Salts
311
Sealing Compounds
1
Sherclin
1
Solvents
134
Stains & Indicators
324
Sugars
67
Tailor-made solutions
1
Testing Standards
4
Uncategorised
18
Water Analysis
12
Cefpirome sulfate
(90028899 | 98753-19-6)
CAS: | 98753-19-6 |
---|---|
Molekularformel: | C22H24N6O9S3 |
Molekulargewicht: | 612.66 |
Verfügbarkeit: | Bitte kontaktieren Sie uns |
---|---|
Downloads: | Produktspezifikation |
90028899-1g | 1g | £40.40 | |
Bulk Menge |
90028899-1g | 1g | €56.60 | |
Bulk Menge |
90028899-1g | 1g | $60.60 | |
Bulk Menge |
Spezifikation
Analysezertifikat
Produktbeschreibung
Product Code | 90028899 | ||||
Product Name | Cefpirome sulfate | ||||
Categories | Antibiotics Bioactive Small Molecules Research Organics & Inorganics | ||||
CAS | 98753-19-6 | ||||
Molecular Formula | C22H24N6O9S3 | ||||
Molecular Weight | 612.66 | ||||
Storage Details | 2 to 8 °C | ||||
Harmonised Tariff Code | 29419000 |
Produktspezifikation
Water | <2.5% | ||||
Total impurity | <1.0% | ||||
Heavy metals | NMT 20ppm | ||||
pH | 1.6 - 2.6 | ||||
Assay | 82% min | ||||
Specific optical rotation | -27 to -33 | ||||
Any Other Impurities | <0.5% | ||||
Appearance | Almost white crystalline powder. | ||||
Manufacturing Date | Month/year |
Sicherheitsinformation
Pictograms |
|
||||
Signal word | none | ||||
Hazard statements |
|
||||
Precautionary statements |
|